L-carnitine attenuates trastuzumab-induced changes in cardiac H9c2 cells
A laboratory study found that L-carnitine attenuated selected signaling, biochemical and viability changes induced by trastuzumab in cardiac H9c2 cells.
A laboratory study found that L-carnitine attenuated selected signaling, biochemical and viability changes induced by trastuzumab in cardiac H9c2 cells.
In a four-group experiment with 28 rats, hydroxytyrosol lowered oxidative DNA damage and selected markers of doxorubicin-related cardiac injury, but ...
A new meta-analysis of six randomized controlled trials finds that long-term exercise significantly attenuates cardiac troponin I elevation in breast ...
The Polish Zebrafish Society has issued comprehensive national recommendations positioning the zebrafish as a rigorous, ethical, and faster alternative to ...
A sweeping review reveals how the chemotherapy drug doxorubicin breaks the heart's mitochondrial and ER recycling systems at multiple checkpoints, ...
Researchers used a Quality by Design approach to engineer doxorubicin-loaded chitosan microbubbles that release the chemotherapy drug under ultrasound, dramatically ...
A new review maps the rapid rise of NK cell immunotherapy for solid tumors and warns that its cardiovascular safety ...
A national survey analysis finds cardiovascular disease prevalence in breast cancer survivors rises sharply after seven years, peaking beyond a ...
A new review in Frontiers in Bioinformatics surveys how machine learning and deep learning models are reshaping toxicity prediction across ...
A new review highlights how microelectrode arrays can simultaneously track electrical, contractile and structural signs of cardiotoxicity in cancer therapy ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine